ANDROPAUSE (MALE MENOPAUSE):
SYMPTOMS, TREATMENT, AND
MEN’S HEALTH SOLUTIONS

Q: What is andropause?
A: Andropause is a gradual decline in testosterone production occurring in men typically between ages forty and seventy, characterised by declining sexual function, reduced energy, mood changes, muscle loss, and metabolic shifts. Unlike menopause in women, which occurs relatively abruptly, andropause develops slowly over years. Testosterone levels decline approximately one percent annually after age thirty. EvolveWell recognises andropause as a legitimate clinical condition requiring assessment and management, not a normal aspect of ageing to be dismissed or ignored.

Q: How does EvolveWell assess and manage andropause?
A: EvolveWell assessment begins with detailed symptom history, sexual function evaluation, and comprehensive testosterone testing including total testosterone, free testosterone, and SHBG levels. Additional testing evaluates metabolic health, cardiovascular risk, prostate function, and bone density. EvolveWell clinicians interpret results in the context of symptoms and individual physiology rather than relying on reference ranges alone. Management options include lifestyle optimisation, supplementation, or testosterone replacement therapy when appropriate. This individualised approach addresses root causes rather than symptoms alone, maximising outcomes and safety.

Q: Who should seek andropause assessment at EvolveWell?
A: Men experiencing symptoms such as declining sexual interest or erectile dysfunction, reduced energy and motivation, mood changes or depression, decreased muscle mass, weight gain, poor sleep, or cognitive fog should seek assessment at EvolveWell. Men concerned about prostate health or cardiovascular risk benefit from comprehensive evaluation. Those with a family history of early andropause or testosterone deficiency may benefit from baseline assessment. EvolveWell helps men understand whether symptoms reflect testosterone deficiency, other medical conditions, or lifestyle factors requiring different interventions.

Q: Who should seek specialist guidance before andropause management at EvolveWell?
A: Men with a personal history of prostate cancer should consult their oncologist before testosterone replacement, as testosterone may increase recurrence risk. Those with untreated sleep apnoea, severe cardiovascular disease, or uncontrolled hypertension require specialist assessment before testosterone therapy. Men with a strong family history of prostate cancer may benefit from specialist consultation regarding individual risk-benefit analysis. EvolveWell conducts thorough suitability screening and coordinates with specialists when complex medical histories are present, ensuring safe, appropriate management.

Q: What realistic outcomes can men expect from andropause management at EvolveWell?
A: Most men experience improved energy, mood, and sexual function within four to eight weeks of starting testosterone replacement therapy, with optimal improvements evident by twelve to sixteen weeks. Muscle mass and strength improvements develop over three to six months with concurrent exercise. Metabolic improvements such as reduced visceral fat occur gradually over months. However, not all symptoms resolve completely, and results depend on baseline testosterone status, overall health, age, and lifestyle factors. EvolveWell sets realistic expectations, emphasising that testosterone therapy improves quality of life but does not reverse ageing.

Q: What is the timeline for andropause management, and how long does treatment typically last?
A: Initial testosterone assessment and optimisation at EvolveWell spans four to twelve weeks, with follow-up testing and dose adjustments as needed. Most men reach optimal symptom relief by twelve to sixteen weeks. Once stable, men are reassessed every six to twelve months with repeat testosterone testing to ensure doses remain appropriate. Some men choose ongoing testosterone replacement indefinitely; others may discontinue after achieving health goals. EvolveWell designs treatment timelines individualised to each man’s needs and preferences rather than applying fixed protocols.

Q: What are the limitations of testosterone replacement therapy, and what risks should men understand?
A: Testosterone therapy can increase red blood cell production, potentially increasing blood clot and stroke risk in some men. It may worsen sleep apnoea if untreated. Testosterone does not improve fertility; in fact, it typically reduces sperm production. Therapy cannot reverse severe erectile dysfunction from vascular disease or neurological damage. Testosterone therapy does not prevent prostate cancer but may increase growth of existing cancer. EvolveWell is transparent about these risks, screens candidates thoroughly, monitors patients closely, and uses the lowest effective doses minimising risk whilst maximising benefit.

Q: How does EvolveWell’s approach to andropause differ from standard GP care?
A: EvolveWell conducts comprehensive testosterone assessment measuring multiple forms rather than relying on single total testosterone values. Clinicians evaluate symptoms and biomarkers together, not in isolation, to confirm testosterone deficiency is responsible for symptoms. EvolveWell integrates testosterone therapy with metabolic health, cardiovascular risk reduction, exercise programming, nutrition optimisation, and stress management, addressing multiple factors influencing male health. Rather than prescribing testosterone routinely, EvolveWell carefully selects appropriate candidates after thorough suitability assessment, using individualised dosing and close monitoring ensuring safety and efficacy.

Q: How does andropause management fit into comprehensive male health optimisation at EvolveWell?
A: Testosterone influences metabolic health, cardiovascular function, bone density, muscle mass, cognitive function, and mood. EvolveWell integrates testosterone assessment with cardiovascular screening, metabolic health evaluation, bone density assessment, and lifestyle optimisation. Testosterone therapy works synergistically with exercise building muscle and strength, nutrition supporting metabolic health, and stress management reducing cortisol interference with testosterone production. This systems-based approach addresses multiple factors influencing male health simultaneously, producing superior outcomes compared to testosterone replacement alone and supporting long-term health optimisation and disease prevention.

Q: Can andropause symptoms be confused with other conditions, and how does EvolveWell differentiate?
A: Yes. Depression, thyroid dysfunction, sleep apnoea, metabolic syndrome, and cardiovascular disease can mimic andropause symptoms such as fatigue, mood changes, and erectile dysfunction. EvolveWell conducts comprehensive assessment including thyroid testing, metabolic screening, sleep evaluation, and cardiovascular assessment to rule out these conditions before attributing symptoms solely to testosterone deficiency. This diagnostic precision prevents misattribution of symptoms to andropause when another treatable condition is responsible, ensuring men receive appropriate, targeted intervention for their actual problem rather than unnecessary testosterone therapy.

Q: What testosterone delivery methods does EvolveWell offer for andropause management?
A: EvolveWell offers multiple testosterone delivery options including intramuscular injections, transdermal patches, topical gels, and subcutaneous pellets. Injections provide consistent levels but require weekly or biweekly administration. Patches and gels offer flexibility and daily dosing adjustment but require consistent application. Pellets provide long-term delivery over three to six months without daily administration. EvolveWell discusses options with each man, considering lifestyle, preference, absorption capacity, and individual response. The flexibility to adjust both dose and delivery method ensures testosterone therapy can be optimised for each man’s unique physiology and lifestyle.

Q: How frequently does EvolveWell monitor men on testosterone replacement therapy?
A: EvolveWell monitors testosterone patients at four weeks post-initiation to assess early response and side effects, then at eight and twelve weeks to evaluate symptom improvement and hormone levels. Once stable, men are reassessed every six to twelve months with repeat testosterone testing, prostate-specific antigen (PSA) screening, haematocrit monitoring, and cardiovascular assessment. This regular oversight ensures testosterone therapy remains safe and effective, allows dose adjustment as physiology changes, and provides early detection of any adverse effects requiring intervention or therapy adjustment. Close monitoring is essential for safe testosterone replacement.

Q: Is erectile dysfunction always caused by testosterone deficiency, and can testosterone therapy resolve it?
A: No. Erectile dysfunction has multiple causes including vascular disease, neurological dysfunction, medication side effects, psychological factors, and poor lifestyle habits. EvolveWell evaluates erectile dysfunction comprehensively, assessing testosterone levels but also cardiovascular function, metabolic health, and psychological factors. Testosterone therapy improves erectile function in men with documented testosterone deficiency but is ineffective if erectile dysfunction stems from other causes. EvolveWell may recommend additional interventions such as cardiovascular optimisation, metabolic health improvement, or specialist urological evaluation alongside or instead of testosterone therapy, depending on identified causes.

Q: What lifestyle changes enhance testosterone levels and andropause management at EvolveWell?
A: Regular resistance exercise and high-intensity interval training stimulate testosterone production and improve sexual function. Adequate sleep, particularly seven to nine hours nightly, is essential for testosterone production. Weight loss through nutrition optimisation improves testosterone levels and metabolic health. Stress management and cortisol reduction support healthy testosterone production, as elevated cortisol suppresses testosterone. Limiting alcohol consumption protects testosterone levels. Adequate zinc and vitamin D intake support testosterone synthesis. EvolveWell integrates these lifestyle interventions with testosterone therapy when appropriate, creating a comprehensive approach addressing multiple factors influencing male hormonal and metabolic health.

Q: Can men on testosterone replacement therapy father children, and what are the implications?
A: Testosterone replacement therapy typically reduces sperm production and fertility. Men seeking to father children should discuss this with EvolveWell clinicians before beginning testosterone therapy. Alternative approaches such as testosterone therapy deferral, lower doses, or human chorionic gonadotropin (hCG) co-therapy may preserve fertility whilst addressing andropause symptoms. Men already on testosterone therapy who wish to father children may benefit from specialist urological consultation regarding fertility preservation options. EvolveWell discusses reproductive goals with men before initiating therapy and helps them make fully informed decisions balancing symptom relief with fertility preservation.

Q: How does EvolveWell educate men about andropause and testosterone management?
A: EvolveWell clinicians explain testosterone’s role in sexual function, energy, mood, muscle health, and metabolic function, helping men understand why testosterone deficiency produces their specific symptoms. Clinicians discuss testosterone testing results in detail, explaining what levels mean and how they relate to symptoms. EvolveWell educates men about testosterone therapy mechanisms, expected timeline for improvement, potential side effects, and monitoring requirements. This educational approach builds health literacy, empowers informed decision-making, and increases engagement with management recommendations. Educated men are more likely to sustain lifestyle changes and adhere to treatment protocols, producing